Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-07 6:55 pm Purchase |
2024-01-16 | 13G | Myomo, Inc. MYO |
Orin Hirschman | 2,838,290 9.900% |
298,290 (+11.74%) |
Filing History |
| 2024-02-07 6:55 pm Sale |
2023-12-31 | 13G | Red Cat Holdings, Inc. RCAT |
Orin Hirschman | 5,026,104 7.000% |
-250,000 (-4.74%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | scPharmaceuticals Inc. SCPH |
Orin Hirschman | 3,106,795 8.700% |
556,561 (+21.82%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2024-01-29 | 13G | SmartKem, Inc. SMTK |
Orin Hirschman | 136,937 9.900% |
136,937 (New Position) |
Filing History |
| 2024-02-07 6:55 pm Sale |
2023-12-31 | 13G | TELA Bio, Inc. TELA |
Orin Hirschman | 1,377,945 5.600% |
-301,336 (-17.94%) |
Filing History |
| 2024-02-07 6:55 pm Sale |
2023-12-31 | 13G | Theratechnologies Inc. THTX |
Orin Hirschman | 3,719,302 8.100% |
-429,761 (-10.36%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | Vaccinex, Inc. VCNX |
Orin Hirschman | 89,076 9.900% |
977 (+1.11%) |
Filing History |
| 2024-02-07 09:22 am Purchase |
2024-02-01 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Orin Hirschman | 255,556 9.900% |
255,556 (New Position) |
Filing History |
| 2024-02-07 09:18 am Purchase |
2024-02-06 | 13G | Immix Biopharma, Inc. IMMX |
Orin Hirschman | 1,455,000 5.800% |
1,455,000 (New Position) |
Filing History |
| 2024-02-07 09:15 am Purchase |
2024-01-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Orin Hirschman | 1,061,509 8.200% |
1,061,509 (New Position) |
Filing History |
| 2024-01-25 07:03 am Sale |
2024-01-18 | 13G | Transphorm, Inc. TGAN |
Orin Hirschman | 1,263,282 2.000% |
-3,831,690 (-75.21%) |
Filing History |
| 2024-01-09 08:12 am Purchase |
2023-12-27 | 13G | Delcath Systems, Inc. DCTH |
Orin Hirschman | 1,539,638 6.800% |
1,539,638 (New Position) |
Filing History |
| 2024-01-04 06:02 am Sale |
2023-12-31 | 13G | GSI Technology, Inc. GSIT |
Orin Hirschman | 835,560 3.300% |
-1,164,440 (-58.22%) |
Filing History |
| 2023-12-21 10:34 am Sale |
2023-12-20 | 13G | CAMP4 Therapeutics Corporation CAMP |
Orin Hirschman | 0 0.000% |
-101,215 (Position Closed) |
Filing History |
| 2023-12-15 06:26 am Purchase |
2023-12-11 | 13G | IN8bio, Inc. INAB |
Orin Hirschman | 4,098,361 9.400% |
4,098,361 (New Position) |
Filing History |
| 2023-12-08 06:10 am Purchase |
2023-12-07 | 13G | Red Cat Holdings, Inc. RCAT |
Orin Hirschman | 5,276,104 7.400% |
5,276,104 (New Position) |
Filing History |
| 2023-12-05 06:01 am Purchase |
2023-11-07 | 13G | Cellectar Biosciences, Inc. CLRB |
Orin Hirschman | 1,915,220 9.900% |
1,915,220 (New Position) |
Filing History |
| 2023-12-04 4:05 pm Purchase |
2023-09-18 | 13G | Elutia Inc. ELUT |
Orin Hirschman | 1,869,530 9.900% |
1,869,530 (New Position) |
Filing History |
| 2023-12-04 4:05 pm Sale |
2023-12-01 | 13G | Airgain, Inc. AIRG |
Orin Hirschman | 0 0.000% |
-725,484 (Position Closed) |
Filing History |
| 2023-11-29 4:32 pm Purchase |
2023-10-26 | 13G | Theratechnologies Inc. THTX |
Orin Hirschman | 4,149,063 9.000% |
4,149,063 (New Position) |
Filing History |